Therapy Areas: Diabetes
U.S. ARKRAY unveils US FDA approved ADAMS A1c HA-8180V system for haemoglobin A1c testing in diabetic patients
19 September 2017 - U.S. ARKRAY Inc (ARKRAY) reported on Monday the availability of the ADAMS A1c HA-8180V system for haemoglobin A1c testing for the diagnosis of diabetes.The company said the ADAMS A...
AstraZeneca reveals results from EXSCEL trial of diabetes drug Byduron
18 September 2017 - United Kingdom-based AstraZeneca has revealed complete results from the EXSCEL (EXenatide Study of Cardiovascular Event Lowering) trial that indicated cardiovascular safety for Byd...
Orthopedic Braces and Supports Market to Reach USD 4.93bn by 2022, MarketsandMarkets Forecasts
18 September 2017 - - The orthopedic braces and supports market is projected to reach USD 4.93bn by 2022 from USD 3.76bn in 2017, at a CAGR of 5.6%, according to a report from India-based Ma...
Lexicon Publishes Study Results of Sotagliflozin in Patients with Type 1 Diabetes in New England Journal of Medicine, Presents Data at EASD 2017
15 September 2017 - - The Woodlands, Texas-based biopharmaceutical company Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has published results of the Phase 3 inTandem3 study of sotagliflozin, an i...
Chakravarthy Named Chief Medical Officer at Axcella Health
14 September 2017 - - US-based biotechnology company Axcella Health has hired Manu Chakravarthy, M.D., Ph.D as chief medical officer and senior vice president of clinical development, the company said...
Poxel to announce data from Phase 2b study of Imeglimin for type 2 diabetes
14 September 2017 - French biopharmaceutical company Poxel SA (EPA: POXEL) is poised to present data from the Imeglimin Phase 2b study conducted in Japan, the company confirmed on Thursday.Poxel, whos...